Risk factors for symptomatic malignant pleural effusion recurrence in patients with actionable mutations in advanced lung adenocarcinoma.

Ke Xu,Xiaodi Wu,Lu Chen,Jingyuan Xie,Xin Hua,Mo Chen, Yuxin Jiang,Hongbing Liu,Fang Zhang,Tangfeng Lv,Yong Song,Ping Zhan

Translational lung cancer research（2023）

引用 0|浏览4

暂无评分

摘要

The findings herein indicated the characteristics of specific patients at high risk for MPE recurrence in lung adenocarcinoma. Patients with actionable mutations benefit more in MPE recurrence and could benefit from targeted therapy and active intrapleural management.

查看译文

关键词

Lung adenocarcinoma, malignant pleural effusion (MPE), recurrence, mutations

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要